Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer

NCT00215722 is registered in ClinicalTrials.gov with Grupo de Investigacao do Cancro Digestivo as lead sponsor.

NCT NCT00215722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00215722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer
Lead sponsor
Grupo de Investigacao do Cancro Digestivo
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2005
Completion date
July 31, 2008
Enrollment
45
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal carcinoma